Filing Details

Accession Number:
0001753926-25-000072
Form Type:
13G Filing
Publication Date:
2025-01-09 19:00:00
Filed By:
Ionic Ventures, LLC
Company:
Avenir Wellness Solutions Inc.
Filing Date:
2025-01-10
SEC Url:
13G Filing
Ownership Summary

Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.

Name Beneficially Owned Number of Shares Beneficially Owned Number of Aggregate Shares Percent of Class
Ionic Ventures, LLC 0 8,306,000 9.5%
Ionic Management, LLC 0 8,306,000 9.5%
Brendan O'Neil 0 8,306,000 9.5%
Keith Coulston 0 8,306,000 9.5%
Filing





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox not checked   Rule 13d-1(b)
Checkbox checked   Rule 13d-1(c)
Checkbox not checked   Rule 13d-1(d)






SCHEDULE 13G



Comment for Type of Reporting Person:  As more fully described in Item 4 of this Statement on Schedule 13G (this ''Schedule 13G''), such shares and percentage are based on 87,231,168 shares of the issuer's common stock, par value $0.001 per share (the ''Common Stock''), outstanding as of the date of this Schedule 13G, which includes the 78,925,168 shares of Common Stock outstanding disclosed in the issuer's Quarterly Report on Form 10-Q for the quarterly period ended September 30, 2024, filed by the issuer with the U.S. Securities and Exchange Commission on November 19, 2024 (the ''Form 10-Q'') and gives effect to the issuance of an aggregate of 8,306,000 shares of Common Stock to the reporting person subsequent to the date of the Form 10-Q.


SCHEDULE 13G



Comment for Type of Reporting Person:  As more fully described in Item 4 of this Schedule 13G, such shares and percentage are based on 87,231,168 shares of Common Stock outstanding as of the date of this Schedule 13G, which includes the 78,925,168 shares of Common Stock outstanding disclosed in the Form 10-Q and gives effect to the issuance of an aggregate of 8,306,000 shares of Common Stock to the reporting person subsequent to the date of the Form 10-Q.


SCHEDULE 13G



Comment for Type of Reporting Person:  As more fully described in Item 4 of this Schedule 13G, such shares and percentage are based on 87,231,168 shares of Common Stock outstanding as of the date of this Schedule 13G, which includes the 78,925,168 shares of Common Stock outstanding disclosed in the Form 10-Q and gives effect to the issuance of an aggregate of 8,306,000 shares of Common Stock to the reporting person subsequent to the date of the Form 10-Q.


SCHEDULE 13G



Comment for Type of Reporting Person:  As more fully described in Item 4 of this Schedule 13G, such shares and percentage are based on 87,231,168 shares of Common Stock outstanding as of the date of this Schedule 13G, which includes the 78,925,168 shares of Common Stock outstanding disclosed in the Form 10-Q and gives effect to the issuance of an aggregate of 8,306,000 shares of Common Stock to the reporting person subsequent to the date of the Form 10-Q.


SCHEDULE 13G


 
Ionic Ventures, LLC
 
Signature:/s/ Ionic Ventures, LLC
Name/Title:Keith Coulston, Manager of Ionic Management, LLC, Manager of Ionic Ventures, LLC
Date:01/10/2025
 
Ionic Management, LLC
 
Signature:/s/ Ionic Management, LLC
Name/Title:Keith Coulston, Manager
Date:01/10/2025
 
Brendan O'Neil
 
Signature:/s/ Brendan O'Neil
Name/Title:Brendan O'Neil
Date:01/10/2025
 
Keith Coulston
 
Signature:/s/ Keith Coulston
Name/Title:Keith Coulston
Date:01/10/2025
Exhibit Information

See Exhibit 1 filed herewith.